| 1481/2682 | US=71 / Enfermagem Poniatowski BC. Menopause. In: Lockwood S. Contemporary issues in women's cancers. London: Jones & Bartlett Publishers, 2008. p. 227-44. ISBN 978-0-7637-2602-7. MENOPAUSA; EXPERIENCIA SINTOMA DA MENOPAUSA; SINTOMAS VASOMOTORES; SINTOMAS UROGENITAIS; TERAPIA DE REPOSICAO HORMONAL; VASOMOTOR; SINTOMAS UROGENITAIS; TERAPIAS ALTERNATIVAS PARA A MENOPAUSA |
| 1482/2682 | US=8 / Dermatologia Fitzpatrick JE. Mucocutaneous complications of antineoplastic therapy. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, editores. Fitzpatrick's dermatology in general medicine. 6th ed. New York: McGraw-Hill, 2008. p. 1337-47. ISBN 978-0-07138076-0. TERAPIA ANTINEOPLASICA; COMPLICACOES MUCOCUTANEAS; FARMACOLOGIA |
| 1483/2682 | US=80 / Biol/Mol Alaoui-Jamali MA, Pinto D. Proteomic profiling of tyrosine kinases as pharmacological endpoints for targeted cancer therapy. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 59-77. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. TIROSINA-QUINASES PROTEICAS; CANCER; TERAPIA-ALVO; PROTEOMICA |
| 1484/2682 | US=80 / Biol/Mol Li D, Hackett J, Chan M, Pennello G, Gutman S. Regulatory issues in the co-development of oncology drugs and proteomic tests: an overview. In: Daoud SS. Cancer proteomics from bench to bedside. New Jersey: Humana press, 2008. p. 237-58. (Cancer Drug Discovery and Development) ISBN 978-1-59745-169-7. |
| 1485/2682 | US=84 / Biol/Mol Liu W, Chua C, Gao Z, Wu X, Cao Y. TGF-B in inflammation and fibrosis: overexpressed truncated TGF-B type II receptor inhibits fibrotic behavior of keloid fibroblasts in vitro and experimental scar formation in vivo. In: Jakowlew SB. Transforming growth Factor-beta in cancer therapy: basic and clinical biology. Amsterdam: Elsevier, 2008. p. 703-21. (Cancer Drug Discovery and Development) ISBN 978-1-58829-714-3. TRUNCATED TGF-B RECEPTOR II; TGF-B SINALIZACAO; FERIR CICATRIZES; QUELOIDE; TERAPIA GENETICA CICATRIZ |
| 1486/2682 | US=84-A / Biol/Mol Wang GY, Hu XH, Zhang RM, Leach L, Luo ZW. Transformig growth factor-B in developing and advanced cancers: TGF-B ligands, TGF-B receptors, and lung cancer. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 79-93. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. DNA METILACAO; CANCER DE PULMAO; TERAPIA DO CANCER; SMAD PROTEINAS; MUTACAO GENETICA; MIGRACAO DO TUMOR; TGF-B LIGANDOS; TGF-B RECEPTORES |
| 1487/2682 | US=84-A / Biol/Mol Bartholin L, Guise T. Transformig growth factor-B in developing and advanced cancers: role of TGF-B in osteolytic bone metastases. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 95-123. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. |
| 1488/2682 | US=84-A / Biol/Mol Saika S. Transformig growth factor-B in developing and advanced cancers: therapeutic effects of adenovirus medated gene transfer of TGF-B signal antagonists on undesirable epithelial-mesenchymal transition and neovascularization. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 367-81. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. TRANSICAO EPITELIAL-MESENQUIMAL; NEOVASCULARIZACAO; CICATRIZACAO DE FERIDAS; FACTOR DE CRESCIMENTO TRANSFORMANTE B; TRANSDUCAO DE SINAL; TERAPIA GENETICA |
| 1489/2682 | US=84-A / Biol/Mol Micke P, Moustakas A, Ohshima M, Kappert K. Transformig growth factor-B in developing and advanced cancers: cancer-associated fibroblasts and the role of TGF-B. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 417-41. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. ASSOCIADAS CANCER FIBROBLASTOS; ESTROMA; ASSOCIADAS CANCER FIBROBLASTOS; TUMOR DO ESTROMA INTERACCAO; MIOFIBROBLASTOS; TERAPIA-ALVO; TGFB-1; MICROARRAY; EXPRESSAO DO GENE; CANCER |
| 1490/2682 | US=84-A / Biol/Mol Datta PK, Mann JR. Development of inhibitors of transforming growth factor-B signaling for therapy: transforming growth factor-B (TGF-B) signaling inhibitors in cancer therapy. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 573-87. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. TGF-B; PEQUENA MOLECULA INIBIDORES; TRANSDUCAO DE SINAL; SUPRESSOR DE TUMOR; PROMOTOR DE TUMOR; BIOMARCADOR; TERAPIA DO CANCER |
| 1491/2682 | US=84-A / Biol/Mol Lacher MD, Korn WM, Akhurst RJ. Development of inhibitors of transforming growth factor-B signaling for therapy: reversal of EMT by small-molecule inibitors of TGF-B type I and II receptors: implications for carcinoma treatment. In: Jakowlew SB. Transforming growth factor-beta in cancer therapy: cancer treatment and therapy. Amsterdam: Elsevier, 2008. p. 707-22. (Cancer Drug Discovery and Development) ISBN 978-1-58829-715-0. TGF-B RECEPTORES; PEQUENAS MOLECULAS INIBIDORES; EPITELIAL PARA MESEACHYMAL TRANSICAO; EMT; METASTASE; VIRUS COXSACKIE E RECEPTOR ADENOVIRUS; TERAPIA DO CANCRO ADENOVIRAL |
| 1492/2682 | US=86 / Biol/Mol Melet A, Song K, Bucur O, Jagani Z, Grassian AR, Khosravi-Far R. Apoptotic pathways in tumor progression and therapy. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 47-79. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. VIAS APOPTOTICAS; PROGRESSAO TUMORAL; TERAPIA DE CANCER; APOPTOSE; INIBIDORES; TRANSDUCAO DE SINAL; ONCOGENE; MAQUINARIA APOPTOTICA; DROGAS QUIMIOTERAPICAS; RESISTENCIA A DROGA |
| 1493/2682 | US=86 / Biol/Mol Tan TT, White E. Therapeutic targeting of death pathways in cancer: mechanisms for activating cell death in cancer cells. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 81-104. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. SEGMENTACAO TERAPEUTICO; VIAS DE MORTE EM CANCER; MECANISMOS; MORTE CELULAR; CELULAS CANCERIGENAS; APOPTOSE; QUIMIOTERAPIA; TERAPIA ALVO; FAMILIA BCL-2; RECEPTORES DE MORTE; INIBIDORES DO SINAL DE TRANSDUCAO |
| 1494/2682 | US=86 / Biol/Mol Hersey P, Zhang XD, Mhaidat N. Overcoming resistance to apoptosis in cancer therapy. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 105-26. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. TERAPIA DO CANCER; RESISTENCIA A APOPTOSE; ONCOGENE; MELANOMA; FAMILIA BCL-2 |
| 1495/2682 | US=86 / Biol/Mol Humphreys RC, Halpern W. Trail receptors: targets for cancer therapy. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 127-58. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. TERAPIA DO CANCER; RECEPTORES TRAIL; APOPTOSE; ANTICORPOS MONOCLONAIS |
| 1496/2682 | US=86 / Biol/Mol Fan Y, Dutta J, Gupta N, Fan G, Gélinas C. Regulation of programmed cell death by NF-kB and its role in tumorigenesis and therapy. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 223-50. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. REGULACAO DA MORTE CELULAR; NF-KB; TUMORIGENESE; TERAPIA; APOPTOSE; NECROSE; FATOR DE TRANSCRICAO; CANCER |
| 1497/2682 | US=86 / Biol/Mol Chauhan D, Hideshima T, Anderson KC. Targeting proteasomes as therapy in multiple myeloma. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 251-60. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. PROTEOSOMAS; SEGMENTACAO; TERAPIA; MIELOMA MULTIPLO; APOPTOSE; RESISTENCIA A DROGA; BORTEZOMIBE |
| 1498/2682 | US=86 / Biol/Mol Dykxhoorn DM, Chowdhury D, Lieberman J. RNA interference and cancer: endogenous pathways and therapeutic approaches. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 299-329. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. RNA DE INTERFERENCIA; CANCER; VIAS ENDOGENAS; MICRORNA; MICROARRAY; PERFIL DO TUMOR; SIRNA; PROGNOSTICO; TERAPIA |
| 1499/2682 | US=86 / Biol/Mol Jagani Z, Khosravi-Far R. Cancer stem cells and impaired apoptosis. In: Khosravi-Far R, White E. Programmed cell death in cancer progression and therapy. New York: Springer, 2008. p. 331-44. (Advances in Experimental Medicina and Biology, 615) ISBN 978-1-4020-6553-8. CELULAS-TRONCO; CANCER; APOPTOSE; TERAPIA; LEUCEMIA; WNT; BMI1 |
| 1500/2682 | US=62 / Mono/Fono Santos JGF. Eficácia do tratamento das disfagias: revisão de literatura. São Paulo: FAP, 2012. 24 p. -[Monografia de Conclusão do Curso de Pós-Graduação Lato Sensu Disfagia Hospitalar Fundação Antonio Prudente. TRANSTORNOS DE DEGLUTICAO. TERAPIA; TRANSTORNOS DE DEGLUTICAO. REABILITACAO; RESULTADO DE TRATAMENTO; NEOPLASIAS LARINGEAS. REABILITACAO |